The impact of the Trump administration’s threats to choke Huawei Technologies reverberated across the global supply chain on Monday, hitting some of the biggest component-makers.
Most of the tainted drugs originated in India and China, which have become popular sources of generic medications and active-drug ingredients as producers and health-care providers try to hold down costs.
Taiwan, home base of many of the world’s top producers of electronics, is helping its companies to seek out new Asian manufacturing hubs outside China as skyrocketing U.S. tariffs threaten to splinter the global tech supply chain.
President Trump weighed in on the state of trade negotiations with China, saying the U.S. is on the cusp of taking in massive tariffs from China — at odds with his economic adviser, who conceded Sunday that U.S. companies and consumers would pay the tariff bill.
China’s push into autonomous vehicles is barely out of first gear, with only a handful of cities allowing limited trials by search-engine giant Baidu, startup Pony.ai, trucker TuSimple Inc. and others since last year.